Total Payments
$18,404
2024 Payments
$1,863
Companies
48
Transactions
652
Medicare Patients
9,747
Medicare Billing
$992,449
Payment Breakdown by Category
Food & Beverage$13,534 (73.5%)
Travel$4,816 (26.2%)
Education$53.73 (0.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,534 | 634 | 73.5% |
| Travel and Lodging | $4,816 | 11 | 26.2% |
| Education | $53.73 | 7 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic Vascular, Inc. | $4,889 | 35 | $0 (2020) |
| Boston Scientific Corporation | $1,532 | 23 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,331 | 88 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $1,078 | 51 | $0 (2024) |
| ASAHI INTECC USA, INC. | $965.59 | 2 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $962.66 | 61 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $905.55 | 61 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $904.84 | 69 | $0 (2024) |
| Amgen Inc. | $593.57 | 29 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $548.46 | 33 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,863 | 86 | Novartis Pharmaceuticals Corporation ($270.34) |
| 2023 | $1,826 | 84 | ABIOMED ($255.34) |
| 2022 | $1,863 | 88 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($257.04) |
| 2021 | $1,136 | 65 | E.R. Squibb & Sons, L.L.C. ($166.45) |
| 2020 | $703.62 | 40 | ATRICURE, INC. ($127.47) |
| 2019 | $2,147 | 75 | Medtronic Vascular, Inc. ($937.82) |
| 2018 | $6,956 | 120 | Medtronic Vascular, Inc. ($3,477) |
| 2017 | $1,911 | 94 | Medtronic Vascular, Inc. ($459.45) |
All Payment Transactions
652 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.94 | General |
| Category: Cardiovascular | ||||||
| 12/11/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $2.95 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/09/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $21.75 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/04/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/22/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $24.85 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/21/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $16.59 | General |
| Category: Cardiovascular | ||||||
| 11/14/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $19.10 | General |
| Category: Cardiovascular | ||||||
| 11/12/2024 | ATRICURE, INC. | EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) | Food and Beverage | In-kind items and services | $165.81 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/08/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/06/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/05/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $23.80 | General |
| Category: Cardiology | ||||||
| 11/04/2024 | CARDIVA MEDICAL, INC. | SAVVYWIRE (Device) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: DEVICES | ||||||
| 10/31/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $17.51 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/21/2024 | Vital Connect, Inc | VITALPATCH RTM (Device) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: CARDIOLOGY | ||||||
| 10/14/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $23.57 | General |
| Category: Cardiology | ||||||
| 10/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.66 | General |
| Category: DIABETES | ||||||
| 10/09/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/08/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/24/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/20/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $4.37 | General |
| Category: Cardiovascular | ||||||
| 09/17/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $24.53 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/13/2024 | Edwards Lifesciences Corporation | EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) (Device) | Food and Beverage | In-kind items and services | $26.31 | General |
| Category: Transcatheter Heart Valves | ||||||
| 09/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $25.05 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/09/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 34 | 2,143 | 2,987 | $862,247 | $221,294 |
| 2022 | 34 | 2,271 | 3,242 | $875,151 | $224,624 |
| 2021 | 39 | 2,503 | 3,398 | $977,097 | $271,269 |
| 2020 | 38 | 2,830 | 3,909 | $1.0M | $275,262 |
Total Patients
9,747
Total Services
13,536
Medicare Billing
$992,449
Procedure Codes
153
All Medicare Procedures & Services
153 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 425 | 645 | $132,225 | $54,558 | 41.3% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 43 | 62 | $112,096 | $22,070 | 19.7% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 50 | 50 | $72,050 | $15,454 | 21.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 96 | 104 | $40,456 | $13,449 | 33.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 102 | 103 | $71,808 | $13,111 | 18.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 89 | 89 | $28,213 | $10,147 | 36.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 159 | 178 | $24,742 | $9,874 | 39.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 197 | 198 | $40,392 | $9,737 | 24.1% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 49 | 98 | $58,800 | $8,902 | 15.1% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 47 | 51 | $48,501 | $8,560 | 17.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 80 | 146 | $20,294 | $8,375 | 41.3% |
| 92933 | Removal of plaque, insertion of stent and balloon dilation of single coronary artery or branch | Facility | 2023 | 16 | 16 | $32,368 | $7,981 | 24.7% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 37 | 148 | $23,236 | $6,917 | 29.8% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 32 | 89 | $14,062 | $3,964 | 28.2% |
| 92978 | Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | Facility | 2023 | 44 | 47 | $25,427 | $3,361 | 13.2% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 67 | 68 | $18,972 | $3,094 | 16.3% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 35 | 42 | $7,896 | $2,323 | 29.4% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 65 | 162 | $16,038 | $2,264 | 14.1% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 44 | 110 | $11,550 | $2,196 | 19.0% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 36 | 39 | $3,003 | $1,480 | 49.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 20 | 20 | $4,140 | $1,313 | 31.7% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 21 | 50 | $10,300 | $1,237 | 12.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 13 | 13 | $3,445 | $1,215 | 35.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 20 | 21 | $2,919 | $1,161 | 39.8% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 113 | 119 | $4,522 | $1,141 | 25.2% |
About Dr. Randy Bottner, MD
Dr. Randy Bottner, MD is a Cardiovascular Disease healthcare provider based in Savannah, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/20/2005. The National Provider Identifier (NPI) number assigned to this provider is 1780673921.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Randy Bottner, MD has received a total of $18,404 in payments from pharmaceutical and medical device companies, with $1,863 received in 2024. These payments were reported across 652 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($13,534).
As a Medicare-enrolled provider, Bottner has provided services to 9,747 Medicare beneficiaries, totaling 13,536 services with total Medicare billing of $992,449. Data is available for 4 years (2020–2023), covering 153 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Savannah, GA
- Active Since 10/20/2005
- Last Updated 06/12/2015
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1780673921
Products in Payments
- GENERAL THERAPIES (Device) $1,120
- LifeVest (Device) $1,078
- ELIQUIS (Drug) $968.24
- ASAHI PTCA Guide Wire (Device) $965.59
- ENTRESTO (Drug) $957.57
- Resolute (Device) $919.46
- XARELTO (Drug) $904.84
- BRILINTA (Drug) $580.95
- Impella (Device) $518.13
- JARDIANCE (Drug) $439.99
- Repatha (Biological) $422.84
- VERQUVO (Drug) $404.57
- LEQVIO (Drug) $351.56
- Micra (Device) $309.15
- FARXIGA (Drug) $263.39
- CAMZYOS (Drug) $246.16
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) $220.73
- PRALUENT (Drug) $210.21
- MICRA (Device) $202.95
- Reveal LINQ (Device) $201.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Savannah
Dr. David Newton, Md, MD
Cardiovascular Disease — Payments: $209,553
Cardiovascular Disease $209,553
Dr. Roy Flood, M.d, M.D
Cardiovascular Disease — Payments: $87,215
Cardiovascular Disease $87,215
Dr. John Spellman, M.d, M.D
Cardiovascular Disease — Payments: $81,240
Cardiovascular Disease $81,240
Mr. Dale Daly, Md, MD
Cardiovascular Disease — Payments: $18,514
Cardiovascular Disease $18,514
Akinniran Abisogun, M.d, M.D
Cardiovascular Disease — Payments: $14,892
Cardiovascular Disease $14,892
Dr. Mark Jenkins, M.d, M.D
Cardiovascular Disease — Payments: $13,126
Cardiovascular Disease $13,126